Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

South Korea To Double Tamiflu Supply To Block Bird Flu

This article was originally published in PharmAsia News

Executive Summary

South Korea plans to double its Tamiflu (oseltamivir phosphate) stockpile by the end of this year, giving it 2.5 million doses of Roche's bird flu drug. The government estimates a supply that large could treat about 5 percent of the population. The administration made the decision at a Cabinet meeting that also cemented plans to establish a task force of several ministries to prevent an outbreak of bird flu. The plans were adopted in the wake of the country's first case of the avian influenza in April. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068439

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel